Drug Trial Radar · NCT06176365
A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease
Last checked: Nov 19, 2026Latest source record: Apr 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
274
Actual
Start
Jan 16, 2024
Primary completion
Dec 3, 2025
Study completion Dec 3, 2025
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Dec 19, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is open to adults who are at least 18 years old and have * a body mass index (BMI) of 35 kg/m² or more and at least one health problem related to their weight, or * a BMI of 27 kg/m² or more and at least two health problems related to their weight. People who have either type 2 diabetes, high blood pressure, or increased blood lipids can take part in this study. Only people who have previously not managed to lose weight by changing their diet can participate. The purpose of this study is to find out whether a medicine called survodutide (BI 456906) helps people living with obesity disease to lose weight. Participants are divided into 3 groups by chance, like drawing names from a hat. 2 groups get different doses of survodutide and 1 group gets placebo. Placebo looks like survodutide but does not contain any medicine. Every participant has a 2 in 3 chance of getting survodutide. Participants inject survodutide or placebo under their skin once a week for about one and a half years. In addition to the study medicine, all participants receive counselling to make changes to their diet and to exercise regularly. Participants are in the study for about 1 year and 7 months. During this time, it is planned that participants visit the study site up to 14 times and receive 6 phone calls by the site staff. The doctors check participants' health and take note of any unwanted effects. The participants' body weight is regularly measured. The results are compared between the groups to see whether the treatment works.
Conditions
- Obesity
Interventions
SurvodutideDrug
once weekly subcutaneous injection
Placebo matching survodutideDrug
once weekly subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage change in body weight from baseline to Week 76Time frame: at baseline, at week 76
- Achievement of body weight reduction ≥5% (yes/no) from baseline to Week 76Time frame: at baseline, at week 76
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Hosokawa Surgery Clinic
Aichi, Nagoya, Japan
Nagoya City University Hospital
Aichi, Nagoya, Japan
Chiba University Hospital
Chiba, Chiba, Japan
Gifu University Hospital
Gifu, Gifu, Japan
Jiyugaoka Yamada Clinic
Hokkaido, Obihiro, Japan
Yamasaki Family Clinic
Hyogo, Amagasaki, Japan
Kobe University Hospital
Hyogo, Kobe, Japan
Motomachi Takatsuka Naika Clinic
Kanagawa, Yokohama, Japan
Morinagaueno Clinic
Kumamoto, Kumamoto, Japan
Yoshimura Clinic
Kumamoto, Kumamoto, Japan
Medical Corporation KEISEIKAI Kajiyama Clinic
Kyoto, Kyoto, Japan
Ijinkai Takeda General Hospital
Kyoto, Kyoto, Japan
Osaka Metropolitan University Hospital
Osaka, Osaka, Japan
OCROM Clinic
Osaka, Suita, Japan
Saino Clinic
Saitama, Tokorozawa, Japan
Dojinkinenkai Meiwa Hospital
Tokyo, Chiyoda-ku, Japan
Suidoubashi Medical Clinic
Tokyo, Chiyoda-ku, Japan
Tokyo-Eki Center-building Clinic
Tokyo, Chuo-ku, Japan
Tokyo Center Clinic
Tokyo, Chuo-ku, Japan
Fukuwa Clinic
Tokyo, Chuo-ku, Japan
Tokyo Asbo Clinic
Tokyo, Chuo-ku, Japan
New Medical Research System Clinic
Tokyo, Hachioji, Japan
Shimamura Kinen Hospital
Tokyo, Nerima-ku, Japan
Clinical Research Hospital Tokyo
Tokyo, Shinjuku-ku, Japan
HS Clinic
Tokyo, Shinjuku-ku, Japan
ToCROM Clinic
Tokyo, Shinjyuku-ku, Japan
Shinei Medical Healthcare Clinic
Tokyo, Suginami-ku, Japan
Ikebukuro Metropolitan Clinic
Tokyo, Toshima-ku, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.